Hirschel B
Division des maladies infectieuses, Hôpital cantonal universitaire, Genève.
Ther Umsch. 1990 Aug;47(8):653-7.
Acyclovir and zidovudine are the two most widely used antiviral drugs. Acyclovir is efficacious against all infections caused by herpes simplex virus, but treatment must start early to be effective. Herpes zoster virus is less susceptible to acyclovir, but high doses shorten the duration of skin lesions, although the effect on post-herpetic neuralgia is uncertain. Zidovudine diminishes short-term mortality in patients with HIV infection and serious opportunistic infections. In those patients, the average increase in life expectancy is about one year. Because of myelotoxicity, frequent monitoring of blood counts is necessary. Recent results in patients who have few or no symptoms of HIV infection indicate that the drug decreases the chance of progressing to AIDS. Therefore, indications for treatment now include asymptomatic patients with unfavourable laboratory parameters.
阿昔洛韦和齐多夫定是两种使用最为广泛的抗病毒药物。阿昔洛韦对所有由单纯疱疹病毒引起的感染均有效,但治疗必须尽早开始才能起效。带状疱疹病毒对阿昔洛韦的敏感性较低,但高剂量使用可缩短皮肤损害的持续时间,尽管对带状疱疹后神经痛的疗效尚不确定。齐多夫定可降低HIV感染且伴有严重机会性感染患者的短期死亡率。在这些患者中,平均预期寿命增加约一年。由于存在骨髓毒性,需要频繁监测血细胞计数。近期针对几乎没有或没有HIV感染症状患者的研究结果表明,该药物可降低发展为艾滋病的几率。因此,目前的治疗指征包括实验室参数不佳的无症状患者。